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1.	 Despite	the	large	number	of	available	registered	dopamine	receptor	
agonists	and	antagonists,	efficacy	remains	limited	and	development	
of	novel	dopaminergic	drugs	remains	a	high	priority	(this thesis).
2.	 Screening	of	novel	dopamine	d2	receptor	antagonists	on	their		
rate	of	dissociation	is	an	effective	method	to	select	compounds		
with	a	favorable	side	effect	profile	(this thesis).
3.	 Dose	equivalency	of	a	new	antipsychotic	dopaminergic	drug		
and	existing	compounds	can	be	established	by	using	the	prolactin	
response,	provided	that	penetration	through	the	blood-brain	barrier	
is	sufficient (De Visser et al, 2001).
4.	 The	generally	accepted	target	range	of	occupancy	of	striatal	d2	
receptors	of	65-80%,for	registered	antipsychotic	drugs,	is	not	
applicable	to	d2	antagonists	with	a	fast	dissociation	constant		
(this thesis).
5.	 Dopamine	d3	receptor	antagonists	are	promising	drug	candidates	
to	achieve	functional	specificity	for	the	mesolimbic	dopaminergic	
pathway	and	to	decrease	craving	in	addicted	subjects	(this thesis).
6.	 Tachykinin	receptor	antagonists	have	been	shown	to	reduce	alcohol	
craving	(George	et	al	2008),	but	also	to	increase	feelings	of	euphoria		
in	methadone	and	opioid	abusers	( Jones et al, 2013; Walsh et al, 2013).	
These	characteristics	could	provide	a	solution	for	the	lack	of	
prolonged	compliance	with	anti-addiction	treatments	in	drug	
abusers.
7.	 Tachykinins	show	a	low	activity	under	physiological	circumstances	
and	an	increased	expression	in	pathological	states.	This	implies	
that	the	acute	effects	of	tachykinin	receptor	antagonists	in	healthy	
volunteers	provide	a	poor	model	for	pharmacodynamic	effects	of	
these	drugs	in	patients	(this thesis).
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8.	 Selective	modulators	of	gabaa	receptor	subtypes	are	promising	drug	
candidates	to	achieve	functional	specificity	for	dopaminergic	pathways,	
contrary	to	the	nonselective	benzodiazepines.
9.	 Alcohol	constitutes	a	dopaminergic	challenge	test.	This	may	offer		
a	practical	advantage	in	the	development	of	anti-addiction	medications,	
since	alcohol	is	also	often	required	for	drug	interaction	studies.
10.	 The	full	disclosure	of	conflicts	of	interests	like	pharmaceutical	industry		
connections	by	authors	offers	a	false	sense	of	transparancy	and	reliability.	
Recent	scandals	of	fraud	by	academics	whilst	all	these	rules	were	adhered	to,	
have	demonstrated	this.	Therefore,	these	requirements	do	not	accomplish	
their	intended	objectives	fully.
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